ProgressImage ProgressImage
Amrutanjan Health Care Ltd
Pharmaceuticals - Indian - Formulations
BSE Code 590006 border-img ISIN Demat INE098F01031 border-img Book Value 112.97 border-img NSE Symbol AMRUTANJAN border-img Div & Yield % 0.63 border-img Market Cap ( Cr.) 2110.19 border-img P/E 38.7 border-img EPS 18.86 border-img Face Value 1
ParticularsMar 2025
()
Mar 2024
()
Mar 2023
()
Mar 2022
()
Mar 2021
()
Mar 2020
()
INCOME :       
Sales Turnover 451.82421.23379.64405.84332.84261.48
Excise Duty 0.000.000.000.000.000.00
Net Sales 451.82421.23379.64405.84332.84261.48
Other Income 17.6816.3514.5415.3811.328.32
Stock Adjustments 0.57-2.151.735.50-5.016.97
Total Income 470.07435.43395.91426.72339.15276.77
EXPENDITURE :       
Raw Materials 223.78209.67183.71185.96135.18124.05
Power & Fuel Cost 3.523.843.062.661.762.02
Employee Cost 59.1047.6948.8148.2341.7039.36
Other Manufacturing Expenses 10.969.8610.388.376.666.78
Selling & Administrative Expenses 92.0289.2386.9584.6864.7261.45
Miscellaneous Expenses 4.706.873.921.872.973.96
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure 394.08367.17336.83331.77252.99237.62
Operating Profit 75.9968.2559.0894.9586.1639.15
Interest 0.330.250.220.580.590.34
Gross Profit 75.6668.0058.8694.3785.5738.81
Depreciation 6.536.065.213.803.674.36
Profit Before Tax 69.1361.9453.6590.5781.9034.45
Tax 17.9715.9414.0123.3919.739.43
Fringe Benefit tax 0.000.000.000.000.000.00
Deferred Tax 0.331.03-0.200.000.98-0.06
Reported Net Profit 50.8344.9739.8367.1961.1925.08
Extraordinary Items 0.000.110.020.010.070.00
Adjusted Net Profit 50.8344.8639.8167.1861.1225.08
Adjustment below Net Profit -0.79-35.320.000.000.00-0.63
P & L Balance brought forward 236.21239.89214.72161.62105.1391.44
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 13.3013.3314.6714.084.7110.76
P & L Balance carried down 272.96236.21239.89214.72161.62105.13
Dividend 0.000.000.005.854.686.14
Preference Dividend 0.000.000.000.000.000.00
Equity Dividend % 460.00460.00460.00460.00420.00210.00
Dividend Per Share(Rs) 4.604.604.604.604.202.10
Earnings Per Share-Unit Curr 17.5815.5613.6322.9920.938.58
Earnings Per Share(Adj)-Unit Curr 17.5815.5613.6322.9920.938.58
Book Value-Unit Curr 112.9799.7899.4790.7073.7554.54
Book Value(Adj)-Unit Curr 112.9799.7899.4790.7073.7554.54

ATTENTION INVESTORS : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day ...Issued in the interest of investors.  Prevent Unauthorized Transactions in your demat account Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......issued in the interest of investors.   KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.

Investor Protection and Arbitration Exchange Circulars and Rules - NSE BSE

Filing of complaints on SCORES – Easy & quick   |    Advisory for Investors   |    AP Details - NSE   |    AP Details - BSE   |    AP Details - MCX
KYC Process Flow   |    Investor Grievance Redressal Process Flow   |   Online Grievance Redressal   |    Voluntary Freezing/Blocking of Trading Account

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing.

x
x
×
Let's Chat
close
refresh